Variant report

Variant	esv1829284
Chromosome Location	chr7:100318927-100337055
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr7:100323056-100323064	K562	blood:	n/a	n/a
2	BHLHE40	chr7:100322927-100323222	GM12878	blood:	n/a	n/a
3	BHLHE40	chr7:100325083-100325234	HepG2	liver:	n/a	n/a
4	BRCA1	chr7:100323452-100323651	Hela-S3	cervix:	n/a	n/a
5	BRCA1	chr7:100322901-100323144	Hela-S3	cervix:	n/a	n/a
6	BRCA1	chr7:100323502-100323569	H1-hESC	embryonic stem cell:	n/a	n/a
7	CCNT2	chr7:100322941-100323060	K562	blood:	n/a	n/a
8	CEBPB	chr7:100323349-100323710	IMR90	lung:	n/a	n/a
9	CEBPB	chr7:100328048-100328277	K562	blood:	n/a	chr7:100328193-100328204
10	CEBPB	chr7:100328044-100328375	HepG2	liver:	n/a	chr7:100328193-100328204
11	CEBPB	chr7:100322878-100323040	K562	blood:	n/a	chr7:100322907-100322918 chr7:100322906-100322923 chr7:100322908-100322919 chr7:100322907-100322920
12	CEBPB	chr7:100328040-100328372	HepG2	liver:	n/a	chr7:100328193-100328204
13	CEBPB	chr7:100324990-100325273	HepG2	liver:	n/a	n/a
14	CEBPB	chr7:100322881-100323134	H1-hESC	embryonic stem cell:	n/a	chr7:100322907-100322918 chr7:100322906-100322923 chr7:100322908-100322919 chr7:100322907-100322920
15	CEBPB	chr7:100322913-100322974	HepG2	liver:	n/a	n/a
16	CEBPB	chr7:100328137-100328308	Hela-S3	cervix:	n/a	chr7:100328193-100328204
17	CEBPB	chr7:100323378-100323661	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr7:100328148-100328292	A549	lung:	n/a	chr7:100328193-100328204
19	CEBPB	chr7:100328099-100328290	IMR90	lung:	n/a	chr7:100328193-100328204
20	CEBPB	chr7:100322905-100323161	Hela-S3	cervix:	n/a	chr7:100322907-100322918 chr7:100322906-100322923 chr7:100322908-100322919 chr7:100322907-100322920
21	CEBPD	chr7:100328091-100328340	HepG2	liver:	n/a	n/a
22	CTCF	chr7:100322700-100323329	A549	lung:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
23	CTCF	chr7:100323020-100323170	GM12868	blood:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
24	CTCF	chr7:100322974-100323151	Fibrobl	skin:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
25	CTCF	chr7:100323000-100323150	HVMF	connective:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
26	CTCF	chr7:100322943-100323147	MCF-7	breast:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
27	CTCF	chr7:100323020-100323170	SK-N-SH_RA	brain:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
28	CTCF	chr7:100322942-100323157	NHEK	skin:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
29	CTCF	chr7:100323000-100323150	GM12865	blood:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
30	CTCF	chr7:100322920-100323070	WI-38	lung:	n/a	n/a
31	CTCF	chr7:100323020-100323170	HMEC	breast:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
32	CTCF	chr7:100322952-100323190	Gliobla	brain:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
33	CTCF	chr7:100323500-100323650	GM12873	blood:	n/a	n/a
34	CTCF	chr7:100323040-100323190	HepG2	liver:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
35	CTCF	chr7:100323020-100323170	AG04449	skin:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
36	CTCF	chr7:100323000-100323150	WERI-Rb-1	eye:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
37	CTCF	chr7:100323000-100323150	HEEpiC	esophagus:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
38	CTCF	chr7:100322905-100323223	GM13977	blood:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
39	CTCF	chr7:100323020-100323170	GM12878	blood:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
40	CTCF	chr7:100329480-100329513	GM13976	blood:	n/a	n/a
41	CTCF	chr7:100322944-100323223	Hela-S3	cervix:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
42	CTCF	chr7:100323240-100323390	HPF	lung:	n/a	n/a
43	CTCF	chr7:100323380-100323530	SK-N-SH_RA	brain:	n/a	n/a
44	CTCF	chr7:100323240-100323390	GM12875	blood:	n/a	n/a
45	CTCF	chr7:100322952-100323173	ProgFib	skin:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
46	CTCF	chr7:100323020-100323170	HPAF	blood vessel:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
47	CTCF	chr7:100322944-100323225	GM12878	blood:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
48	CTCF	chr7:100322979-100323118	H1-hESC	embryonic stem cell:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
49	CTCF	chr7:100323020-100323170	BE2_C	brain:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
50	CTCF	chr7:100323280-100323430	HFF-Myc	foreskin:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:100330872-100330922	HCT-116	colon:	n/a
2	chr7:100330872-100330922	HCT-116	colon:	n/a
3	chr7:100321217-100321267	NT2-D1	testis:	n/a
4	chr7:100321217-100321267	GM12878	blood:	n/a
5	chr7:100321217-100321267	HAEpiC	amniotic membrane:	n/a
6	chr7:100330872-100330922	NB4	blood:	n/a
7	chr7:100330109-100330159	A549	lung:	n/a
8	chr7:100321217-100321267	LNCaP	prostate:	n/a
9	chr7:100324222-100324272	CMK	blood:	n/a
10	chr7:100324222-100324272	AG09319	gingival:	n/a
11	chr7:100330872-100330922	Jurkat	blood:	n/a
12	chr7:100330872-100330922	NT2-D1	testis:	n/a
13	chr7:100321217-100321267	A549	lung:	n/a
14	chr7:100321217-100321267	NHDF-neo	bronchial:	n/a
15	chr7:100330109-100330159	AG10803	skin:	n/a
16	chr7:100330587-100330637	H1-hESC	embryonic stem cell:	embryo
17	chr7:100330872-100330922	Caco-2	colon:	n/a
18	chr7:100324222-100324272	BE2_C	brain:	n/a
19	chr7:100324222-100324272	IMR90	lung:	fetal
20	chr7:100324222-100324272	PrEC	prostate:	n/a
21	chr7:100330109-100330159	HCPEpiC	choroid plexus:	n/a
22	chr7:100330872-100330922	AG09309	skin:	n/a
23	chr7:100330872-100330922	GM12891	blood:	n/a
24	chr7:100330109-100330159	AG09319	gingival:	n/a
25	chr7:100330587-100330637	Caco-2	colon:	n/a
26	chr7:100321217-100321267	ovcar-3	ovarian:	n/a
27	chr7:100330587-100330637	HPAEpiC	pulmonary alveolar:	n/a
28	chr7:100330587-100330637	T-47D	breast:	n/a
29	chr7:100324222-100324272	HL-60	blood:	n/a
30	chr7:100330109-100330159	MCF10A-Er-Src	breast:	n/a
31	chr7:100330587-100330637	SK-N-SH_RA	brain:	n/a
32	chr7:100324222-100324272	HPAEpiC	pulmonary alveolar:	n/a
33	chr7:100321217-100321267	Caco-2	colon:	n/a
34	chr7:100330587-100330637	HL-60	blood:	n/a
35	chr7:100330587-100330637	HMEC	breast:	n/a
36	chr7:100324222-100324272	RPTEC	kidney:	n/a
37	chr7:100330109-100330159	GM12878	blood:	n/a
38	chr7:100330587-100330637	NT2-D1	testis:	n/a
39	chr7:100330587-100330637	HepG2	liver:	n/a
40	chr7:100330587-100330637	PrEC	prostate:	n/a
41	chr7:100330109-100330159	Hela-S3	cervix:	n/a
42	chr7:100330109-100330159	AG04449	skin:	fetal
43	chr7:100330109-100330159	H1-hESC	embryonic stem cell:	embryo
44	chr7:100330872-100330922	HRPEpiC	eye:	n/a
45	chr7:100324222-100324272	NT2-D1	testis:	n/a
46	chr7:100330109-100330159	HCT-116	colon:	n/a
47	chr7:100321217-100321267	HL-60	blood:	n/a
48	chr7:100330109-100330159	GM12891	blood:	n/a
49	chr7:100330587-100330637	NB4	blood:	n/a
50	chr7:100330109-100330159	HAEpiC	amniotic membrane:	n/a

No.	Distal block	Cell Line	Cell type
1	chr7:100317007..100319008-chr7:100325168..100326733,2	K562	blood:
2	chr7:100288252..100292867-chr7:100319528..100322364,4	K562	blood:
3	chr7:100325203..100328007-chr7:100356386..100357913,2	K562	blood:
4	chr7:100326112..100327796-chr7:100392464..100395372,2	MCF-7	breast:
5	chr7:100302051..100306591-chr7:100312993..100321692,11	MCF-7	breast:
6	chr7:100302553..100308135-chr7:100314195..100322207,16	MCF-7	breast:
7	chr7:100315257..100318069-chr7:100320272..100323098,2	MCF-7	breast:
8	chr7:100317495..100321039-chr7:100423744..100425687,3	MCF-7	breast:
9	chr7:100315279..100318194-chr7:100320126..100322658,3	K562	blood:
10	chr7:100183516..100185859-chr7:100318860..100320461,2	MCF-7	breast:
11	chr7:100321531..100325332-chr7:100423998..100426364,3	MCF-7	breast:
12	chr7:100161316..100162153-chr7:100322612..100323132,2	K562	blood:
13	chr7:100291635..100293380-chr7:100321369..100322955,2	MCF-7	breast:
14	chr7:100322778..100325308-chr7:100423819..100426319,3	MCF-7	breast:
15	chr7:100303316..100305278-chr7:100323603..100325231,2	K562	blood:
16	chr7:100302568..100303662-chr7:100322644..100323525,3	K562	blood:
17	chr7:100302588..100303466-chr7:100322910..100323642,3	MCF-7	breast:
18	chr7:100074435..100077431-chr7:100322288..100324848,2	MCF-7	breast:
19	chr7:100314177..100318194-chr7:100318771..100321626,3	K562	blood:
20	chr7:100336156..100338514-chr7:100343827..100346025,2	K562	blood:
21	chr7:100161665..100162171-chr7:100322646..100323567,2	MCF-7	breast:
22	chr7:100181969..100184766-chr7:100322000..100326304,4	MCF-7	breast:
23	chr7:100319576..100322114-chr7:100397770..100400557,3	MCF-7	breast:
24	chr7:100324153..100326301-chr7:100361628..100364421,2	K562	blood:

Variant related genes	Relation type
ZAN	TF binding region
ZAN	CpG island
ENSG00000130427	chromatin interactions
ENSG00000106336	chromatin interactions
ENSG00000196411	chromatin interactions
ENSG00000166925	chromatin interactions
ENSG00000077454	chromatin interactions
ENSG00000172336	chromatin interactions
ENSG00000146828	chromatin interactions

Extended variants
information (count: 716 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:716 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs192596879	chr7:100318974-100318975	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs537328250	chr7:100318975-100318976	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs75085169	chr7:100319083-100319084	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs199674511	chr7:100319147-100319148	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs367727871	chr7:100319149-100319150	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs372196419	chr7:100319164-100319165	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs77762674	chr7:100319204-100319205	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs541174516	chr7:100319206-100319207	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs73409072	chr7:100319221-100319222	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs140045752	chr7:100319275-100319276	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs200020971	chr7:100319279-100319280	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs149877548	chr7:100319314-100319315	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs200154608	chr7:100319334-100319335	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs368301789	chr7:100319335-100319336	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs530387518	chr7:100319345-100319346	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs144915159	chr7:100319364-100319365	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs372329986	chr7:100319367-100319368	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs564752996	chr7:100319378-100319379	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs528794339	chr7:100319401-100319402	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs74701778	chr7:100319416-100319417	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs80106374	chr7:100319425-100319426	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs529387268	chr7:100319439-100319440	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs551129920	chr7:100319478-100319479	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs569389453	chr7:100319484-100319485	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs112531112	chr7:100319492-100319493	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs570479773	chr7:100319537-100319538	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs375613216	chr7:100319554-100319555	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs201945162	chr7:100319566-100319567	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs376474367	chr7:100319570-100319571	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs201069425	chr7:100319586-100319587	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs61735970	chr7:100319596-100319597	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs369033773	chr7:100319600-100319601	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs62483572	chr7:100319633-100319634	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs570715685	chr7:100319640-100319641	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs34937405	chr7:100319653-100319654	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs57694744	chr7:100319662-100319663	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs111249118	chr7:100319681-100319682	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs373163118	chr7:100319722-100319723	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs186851237	chr7:100319784-100319785	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs574580055	chr7:100319797-100319798	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs541635467	chr7:100319798-100319799	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs556123439	chr7:100319853-100319854	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs78511541	chr7:100319906-100319907	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs507392	chr7:100319936-100319937	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs138641695	chr7:100320013-100320014	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs537893817	chr7:100320126-100320127	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs10550542	chr7:100320132-100320133	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs71517123	chr7:100320133-100320134	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs112363946	chr7:100320135-100320136	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs72104922	chr7:100320143-100320144	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Chronic myeloid leukemia	21384125	CNVD
Bladder cancer	21909424	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	16608533	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Liver carcinoma	19366792	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Adenocarcinoma	19607727	CNVD
Multiple myeloma	16461302	CNVD
Breast cancer	21858162	CNVD
Emphysema	19352772	CNVD
Effusion lymphoma	18079361	CNVD
Medulloblastoma	17653508	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	19401682	CNVD
Neuroticism	17667963	CNVD
Breast cancer	21509527	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:225 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:100317200-100319400	Bivalent Enhancer	Fetal Intestine Small	intestine
2	chr7:100317600-100319400	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
3	chr7:100317800-100319000	Bivalent Enhancer	Primary hematopoietic stem cells	blood
4	chr7:100317800-100319000	Bivalent Enhancer	Stomach Smooth Muscle	stomach
5	chr7:100317800-100319200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
6	chr7:100317800-100319200	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
7	chr7:100317800-100319200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr7:100317800-100319400	Bivalent Enhancer	Fetal Muscle Leg	muscle
9	chr7:100317800-100321000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
10	chr7:100318000-100319000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
11	chr7:100318000-100319000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
12	chr7:100318000-100319000	Bivalent Enhancer	Fetal Stomach	stomach
13	chr7:100318000-100319200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
14	chr7:100318000-100319400	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr7:100318000-100319600	Enhancers	Pancreas	Pancrea
16	chr7:100318000-100319800	Bivalent Enhancer	Colonic Mucosa	Colon
17	chr7:100318400-100319000	Bivalent Enhancer	Spleen	Spleen
18	chr7:100318400-100319200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
19	chr7:100318400-100319400	Flanking Active TSS	Liver	Liver
20	chr7:100318600-100319000	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
21	chr7:100318600-100319000	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
22	chr7:100318600-100319000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr7:100318600-100319000	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr7:100318600-100319200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
25	chr7:100318600-100319200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
26	chr7:100318600-100320400	Flanking Active TSS	HepG2	liver
27	chr7:100318800-100319000	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
28	chr7:100318800-100319000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
29	chr7:100318800-100319000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr7:100318800-100319000	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
31	chr7:100318800-100319000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
32	chr7:100318800-100319000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells short term culture	blood
33	chr7:100318800-100319000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr7:100318800-100319000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr7:100318800-100319000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
36	chr7:100318800-100319000	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
37	chr7:100318800-100319200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
38	chr7:100318800-100319200	Enhancers	Right Atrium	heart
39	chr7:100318800-100319400	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
40	chr7:100318800-100319400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
41	chr7:100318800-100319400	Enhancers	K562	blood
42	chr7:100318800-100319600	Bivalent Enhancer	Placenta	Placenta
43	chr7:100319000-100319200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
44	chr7:100319000-100319200	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr7:100319000-100319200	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
46	chr7:100319000-100319200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr7:100319000-100319200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr7:100319000-100319200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
49	chr7:100319000-100319200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr7:100319000-100319200	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links